Research Article
Outcomes of a PBM-Aligned Single-Unit Platelet Transfusion Policy in Severe UGI Bleeding
1. Abstract 1.1. Introduction Platelet transfusion practices in patients with upper gastrointestinal (UGI) bleeding have traditionally varied, with limited consensus on optimal dosing or thresholds especially for severe cases. Our institution implemented a restrictive, single-unit platelet transfusion policy as part of a broader patient blood management (PBM) initiative.
Liver Transplantation and Survival in Hepatocellular Carcinoma and Viral Hepati tis: A 19-Year Nationwide Cohort from Taiwan
1. Abstract 1.1. Background Liver transplantation (LT) is the definitive therapy for end-stage liver disease and hepatocellular carcinoma (HCC). However, in HBV-endemic regions, the allocation-relevant implications of the viral hepatitis status, waiting time, age, and donor type remain in completely defined in real-world transplant systems.
Surgical Management in Sacrococcygeal Pilonidal Sinus Disease Depending on The Suggested Staging System
1. Abstract 1.1. Background The optimal treatment for the sacrococcygeal pilonidal disease has not been established. Recurrence rates vary by surgical technique. Recurrence wasn’t the only factor in choosing the optimal technique. The procedure should be easy, inexpensive, have few com plications, and allow the patient to return to work or routine
Morphin Colic Or Morphin-Induced Sphincter of Oddi Dysfunction Syndrome: Analytical Evidence
1. Abstract 1.1. Introduction Morphine-induced biliary colic is a complication that has been de- scribed for years. Morphine can cause dysfunction and spasms of the sphincter of Oddi, raising intraciliary pressure and increasing the risk of biliary symptoms and pancreatitis. Its exact incidence is not clearly established, but it is considered a very rare.
Taking a Closer Look: A Systematic Review of Masked Steatosis of the Liver Using PRISMA Guidelines
1. Abstract 1.1. Background Masked steatosis, also known as lean non-alcoholic fatty liver dis ease (lean NAFLD), represents a challenging clinical entity where hepatic steatosis occurs in individuals with normal body mass in dex (BMI <25 kg/m²). This condition is often underdiagnosed due to the misconception that fatty liver disease primarily affects over weight or …
Demographic And Clinical Profile of Chronic Liver Disease Patients in A Tertiary Care Hospital in New Delhi, India
1. Abstract Chronic liver disease in the clinical context is a disease process that causes progressive destruction and regeneration of the liver parenchyma leading to fibrosis and cirrhosis.
Serum Metabolites in the Modulation of Inflammatory Factors on Hepatic Cancer: Mendelian Randomization and Mediation Analysis
1. Abstract 1.1. Objective To explore the causal relationships between inflammatory factors and hepatic cancer and identify the role of serum metabolites as potential mediators.
Positioning The Molecular Characteristics of The Laterally Spreading Tumors Different from The Colorectal Cancer
1. Abstract 1.1. Background Two classical models have been proposed for the development of colorectal cancer (CRC) from colon epithelial cells.
‘DRESS’ from a Gastroenterology & Hepatology Perspective
1. Abstract Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome is an uncommon but potentially life-threatening form of adverse drug reaction (ADR), most frequently reported with antiepileptics and antibiotics.
